Hari Govind International Ltd (HGIL) has received approval from the Bombay Stock Exchange (BSE) to list 6,67,500 equity shares of Rs. 10 each, allotted on a preferential basis to non-promoter investors. This marks a key step in strengthening the company’s capital structure and expanding its shareholder base.
Key Details of the Share Issuance
| Aspect | Details |
| Number of Shares | 6,67,500 |
| Face Value | Rs. 10 each |
| Allotment Type | Preferential basis |
| Allottees | Non-promoters |
| Distinctive Numbers | 7,857,501 to 8,525,000 |
| Issue Price | At par (Rs. 10) |
Listing Approval & Next Steps
- BSE granted listing approval on November 11, 2025.
- Pending actions before trading can commence:
- Filing confirmation letters from NSDL/CDSL about crediting shares to beneficiary accounts.
- Confirming admission of new capital to the depository system.
- Applying for trading approval within seven working days of receiving listing approval to avoid penalties.
Company Communication
- HGIL informed BSE about the approval on November 12, 2025, in compliance with SEBI LODR Regulation 30.
- The notification was signed by Jugal Kishore Harikishan Maniyar, Whole-time Director of the company.
Implications for Investors
- The preferential allotment to non-promoters may alter the shareholding pattern.
- Investors will monitor liquidity and market impact once the newly listed shares begin trading.
- Completion of regulatory formalities will mark the final step in making these shares available on the exchange.
Summary
Hari Govind International’s 6.67 lakh preferential shares listing approval by BSE is a strategic move to enhance capital structure and broaden ownership. With regulatory requirements pending, investors should track the trading commencement and potential impact on shareholding and liquidity.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.